European Archives - Page 176 of 1301 - European Medical Journal

Paediatric HIV Study Backs New Second-Line Antiretroviral Therapy

A new study provides strong evidence supporting the use of dolutegravir and TAF-emtricitabine for second-line antiretroviral therapy in children.

Increasing UV Exposure and Rising Melanoma Risk in Canada

Young adults (18–29 years) had the highest UV exposure and sunburn rates, and were least likely to use protective clothing.

Combination Therapy Improves Outcomes in Prostate Cancer

he analysis also highlighted that treatment intensification with enzalutamide benefited patients regardless of baseline PSA.

Brensocatib Reduces Exacerbations in Patients with Bronchiectasis

A once-daily oral therapy targeting neutrophilic inflammation has shown promise in reducing exacerbations in patients with bronchiectasis.

ESMO Breast Cancer 2025: Gut Microbiome Linked to Breast Cancer Recurrence

New research presented at ESMO Breast 2025 reveals that certain gut bacteria and microbial functions are more common in breast cancer patients who later experience recurrence, highlighting the potential of the gut microbiome as a biomarker for relapse risk.

ESMO Breast Cancer 2025: Alcohol Increases Breast Cancer Risk but Not Prognosis

New research presented at ESMO Breast 2025 shows that alcohol consumption raises the risk of developing breast cancer, particularly hormone receptor-positive types, but does not appear to worsen survival or recurrence in those already diagnosed.

ESMO Breast Cancer 2025: DNA Repair Mutations May Reduce Therapy Response

New data from ESMO Breast 2025 indicate that inherited DNA repair mutations could affect the effectiveness of CDK4/6 inhibitors in treating advanced breast cancer, with mutation carriers showing lower response rates and shorter survival trends.

Seasonal Allergy Symptoms Improved With New Biologic Treatment

The PHECDA trial evaluated stapokibart as an add-on therapy during pollen season in adults with moderate-to-severe seasonal allergic rhinitis.

EuroPCR 2025: 10-year Results of the DANAMI-3-PRIMULTI Trial

Ten-year data show complete revascularisation reduces repeat procedures in STEMI patients with multivessel disease.

Breaking the silence: the patient-doctor perspective on new understanding and communication in COPD management